Progression of Coronary Atherosclerosis After Heart Transplantation on Electron-beam Computed Tomography

Friedrich D Knollmann, Franziska Stühmer, Hans Lehmkuhl, Roland Felix, Roland Hetzer

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Rationale and Objectives: Cardiac transplant vasculopathy is the most important long-term complication of heart transplantation, with overlapping features with conventional, atherosclerotic coronary artery disease. The aim of this study was to determine the progression of coronary artery disease after heart transplantation by measuring total coronary calcium load. Materials and Methods: After heart transplantation, 185 patients were serially examined using electron-beam computed tomography for coronary calcium load for clinical reasons. The mean time between the initial examination and the follow-up scan was 566 days (range, 126-1,436). Coronary calcium load was measured by the Agatston method, and the total calcium scores at both examinations were compared between patients taking and those not taking lipid-lowering medications (statins). Results: Patients not taking statins (n = 94) displayed a median annualized percentage increase in total calcium score of 0 Agatston units, whereas patients taking at least the lowest recommended daily dose of a statin (n = 84) displayed an annualized percentage decrease of 11 Agatston units. The difference was not statistically significant (Wilcoxon's rank-sum test, P = .35). Only 17 patients had increases of > 24 Agatston units, and eight of them were taking statins (χ2 test, P = .99). Conclusion: The annual rate of progression of coronary calcium load after heart transplantation is low. In this investigation, no beneficial effects of statins could be detected.

Original languageEnglish (US)
Pages (from-to)194-199
Number of pages6
JournalAcademic Radiology
Volume16
Issue number2
DOIs
StatePublished - Feb 2009
Externally publishedYes

Fingerprint

X Ray Computed Tomography
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Heart Transplantation
Coronary Artery Disease
Calcium
Nonparametric Statistics
Transplants
Lipids

Keywords

  • computed tomography
  • coronary disease
  • Heart transplantation

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Progression of Coronary Atherosclerosis After Heart Transplantation on Electron-beam Computed Tomography. / Knollmann, Friedrich D; Stühmer, Franziska; Lehmkuhl, Hans; Felix, Roland; Hetzer, Roland.

In: Academic Radiology, Vol. 16, No. 2, 02.2009, p. 194-199.

Research output: Contribution to journalArticle

Knollmann, Friedrich D ; Stühmer, Franziska ; Lehmkuhl, Hans ; Felix, Roland ; Hetzer, Roland. / Progression of Coronary Atherosclerosis After Heart Transplantation on Electron-beam Computed Tomography. In: Academic Radiology. 2009 ; Vol. 16, No. 2. pp. 194-199.
@article{d9ad3cd2d1784281876ec8b9efdf5ee5,
title = "Progression of Coronary Atherosclerosis After Heart Transplantation on Electron-beam Computed Tomography",
abstract = "Rationale and Objectives: Cardiac transplant vasculopathy is the most important long-term complication of heart transplantation, with overlapping features with conventional, atherosclerotic coronary artery disease. The aim of this study was to determine the progression of coronary artery disease after heart transplantation by measuring total coronary calcium load. Materials and Methods: After heart transplantation, 185 patients were serially examined using electron-beam computed tomography for coronary calcium load for clinical reasons. The mean time between the initial examination and the follow-up scan was 566 days (range, 126-1,436). Coronary calcium load was measured by the Agatston method, and the total calcium scores at both examinations were compared between patients taking and those not taking lipid-lowering medications (statins). Results: Patients not taking statins (n = 94) displayed a median annualized percentage increase in total calcium score of 0 Agatston units, whereas patients taking at least the lowest recommended daily dose of a statin (n = 84) displayed an annualized percentage decrease of 11 Agatston units. The difference was not statistically significant (Wilcoxon's rank-sum test, P = .35). Only 17 patients had increases of > 24 Agatston units, and eight of them were taking statins (χ2 test, P = .99). Conclusion: The annual rate of progression of coronary calcium load after heart transplantation is low. In this investigation, no beneficial effects of statins could be detected.",
keywords = "computed tomography, coronary disease, Heart transplantation",
author = "Knollmann, {Friedrich D} and Franziska St{\"u}hmer and Hans Lehmkuhl and Roland Felix and Roland Hetzer",
year = "2009",
month = "2",
doi = "10.1016/j.acra.2008.07.014",
language = "English (US)",
volume = "16",
pages = "194--199",
journal = "Academic Radiology",
issn = "1076-6332",
publisher = "Elsevier USA",
number = "2",

}

TY - JOUR

T1 - Progression of Coronary Atherosclerosis After Heart Transplantation on Electron-beam Computed Tomography

AU - Knollmann, Friedrich D

AU - Stühmer, Franziska

AU - Lehmkuhl, Hans

AU - Felix, Roland

AU - Hetzer, Roland

PY - 2009/2

Y1 - 2009/2

N2 - Rationale and Objectives: Cardiac transplant vasculopathy is the most important long-term complication of heart transplantation, with overlapping features with conventional, atherosclerotic coronary artery disease. The aim of this study was to determine the progression of coronary artery disease after heart transplantation by measuring total coronary calcium load. Materials and Methods: After heart transplantation, 185 patients were serially examined using electron-beam computed tomography for coronary calcium load for clinical reasons. The mean time between the initial examination and the follow-up scan was 566 days (range, 126-1,436). Coronary calcium load was measured by the Agatston method, and the total calcium scores at both examinations were compared between patients taking and those not taking lipid-lowering medications (statins). Results: Patients not taking statins (n = 94) displayed a median annualized percentage increase in total calcium score of 0 Agatston units, whereas patients taking at least the lowest recommended daily dose of a statin (n = 84) displayed an annualized percentage decrease of 11 Agatston units. The difference was not statistically significant (Wilcoxon's rank-sum test, P = .35). Only 17 patients had increases of > 24 Agatston units, and eight of them were taking statins (χ2 test, P = .99). Conclusion: The annual rate of progression of coronary calcium load after heart transplantation is low. In this investigation, no beneficial effects of statins could be detected.

AB - Rationale and Objectives: Cardiac transplant vasculopathy is the most important long-term complication of heart transplantation, with overlapping features with conventional, atherosclerotic coronary artery disease. The aim of this study was to determine the progression of coronary artery disease after heart transplantation by measuring total coronary calcium load. Materials and Methods: After heart transplantation, 185 patients were serially examined using electron-beam computed tomography for coronary calcium load for clinical reasons. The mean time between the initial examination and the follow-up scan was 566 days (range, 126-1,436). Coronary calcium load was measured by the Agatston method, and the total calcium scores at both examinations were compared between patients taking and those not taking lipid-lowering medications (statins). Results: Patients not taking statins (n = 94) displayed a median annualized percentage increase in total calcium score of 0 Agatston units, whereas patients taking at least the lowest recommended daily dose of a statin (n = 84) displayed an annualized percentage decrease of 11 Agatston units. The difference was not statistically significant (Wilcoxon's rank-sum test, P = .35). Only 17 patients had increases of > 24 Agatston units, and eight of them were taking statins (χ2 test, P = .99). Conclusion: The annual rate of progression of coronary calcium load after heart transplantation is low. In this investigation, no beneficial effects of statins could be detected.

KW - computed tomography

KW - coronary disease

KW - Heart transplantation

UR - http://www.scopus.com/inward/record.url?scp=58049205554&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58049205554&partnerID=8YFLogxK

U2 - 10.1016/j.acra.2008.07.014

DO - 10.1016/j.acra.2008.07.014

M3 - Article

VL - 16

SP - 194

EP - 199

JO - Academic Radiology

JF - Academic Radiology

SN - 1076-6332

IS - 2

ER -